In about 70 percent of all clinical decisions, in-vitro diagnostics (IVD) is a very important healthcare resource not only for disease detection but also for monitoring a patient's condition, deciding the line of treatment, seeing that the treatment is complete, or to decide whether there is a cure, or for prognosis.
In India, the laboratory and diagnostic business is at a crucial juncture, as it is changing from a profit-driven area to a customer-centric stream, and is in the course of becoming the soul of the healthcare sector, given the rising need of early detection and monitoring demanded today by several life-threatening diseases.
In recent times, there has been plenty of advances in the IVD space, whether at the genomics, the molecular diagnostics, the technology, instrumentation, materials used, or the software solution levels. The Covid-19 pandemic accelerated this advancement. The global in-vitro diagnostics (IVD) market size is projected to reach $96.0 billion by 2025 from $84.5 billion in 2020, according to a ResearchAnd Markets report. According to the same research firm, the India IVD (Instruments & Reagents) market is likely to reach $1.8 billion mark by 2025.
The emerging technologies
Thanks to the demands of the Covid era, polymerase chain reaction (PCR) testing has become mainstream with its ability to quickly churn out results using the same sample for multiple detections, informs Chandrashekhar Nair, Co-Founder and CTO, Molbio Diagnostics.
Bu hikaye Healthcare Radius dergisinin January 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Healthcare Radius dergisinin January 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
Granules' Visakhapatnam - Unit V facility passes FDA inspection
Granules India's Unit V facility in Visakhapatnam has completed US FDA inspection with zero 483 observations.
Mankind to set up 'Digital Smart Classrooms' in villages
Under the project, Mankind Pharma to equip 220 government schools from Uttar Pradesh, Himachal Pradesh, and Uttarakhand with learning tools and technology.
Indegene acquires medical writing player from Germany
Indegene acquires Trilogy Writing & Consulting GmbH, enhancing medical writing capabilities for life sciences companies.
Medulance bags 25.06 cr series-A VC funding
Latest VC funding to be invested in expanding emergency healthcare in India.
HUMAN TOUCH IN HEALTHCARE
Healthcare must prioritize empathy, not efficiency, for better patient experience, moving from cost center to core strategy, argues author
SMART BANDAGES A REVOLUTION IN WOUND CARE
Wound care is about to get a technological upgrade! See how next-generation intelligent dressings may help to fight infections and assist in the fast healing of wounds
THE EMERGING THREAT OF LUPUS
Explore the prevalence and growth rates of Lupus in India and ways to tackle this emerging healthcare challenge.
INDIA'S NURSES' SHORTAGE: FINDING CURE
The acute scarcity of nurses is burdening India's healthcare system, risking patient care outcomes. Explore the way forward.
New guidelines to address fluid management in hospitalized patients
API and Kenvue India release guidelines for managing oral fluids, electrolytes, and energy in non-diarrheal patients for hospitals in India.
HealthTech hiring stays strong despite funding slowdown - Report
India's HealthTech hiring demonstrates resilience with employment surging by nine percent amidst a funding deceleration.